Search research articles
Contact Us
Filters
Showing results (51-60 of 62) with videos related to
Page
of 7
Sort By:
Toxicology and Applied Pharmacology
|
May 18, 2000
A physiological toxicokinetic model for exogenous and endogenous ethylene and ethylene oxide in rat, mouse, and human: formation of 2-hydroxyethyl adducts with hemoglobin and DNA
G A Csanády, B Denk, C Pütz, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis
|
February 1, 1993
Modeling receptor-mediated processes with dioxin: implications for pharmacokinetics and risk assessment
M E Andersen, J J Mills, M L Gargas, et al.
Regulatory Toxicology and Pharmacology : RTP
|
August 16, 2005
Cancer dose--response assessment for acrylonitrile based upon rodent brain tumor incidence: use of epidemiologic, mechanistic, and pharmacokinetic support for nonlinearity
C R Kirman, M L Gargas, G M Marsh, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis
|
November 26, 2004
Addressing nonlinearity in the exposure-response relationship for a genotoxic carcinogen: cancer potency estimates for ethylene oxide
C R Kirman, L M Sweeney, M J Teta, et al.
Toxicology and Applied Pharmacology
|
March 15, 1991
Physiologically based pharmacokinetic modeling with dichloromethane, its metabolite, carbon monoxide, and blood carboxyhemoglobin in rats and humans
M E Andersen, H J Clewell, M L Gargas, et al.
Toxicology and Applied Pharmacology
|
May 18, 2000
A toxicokinetic study of inhaled ethylene glycol monomethyl ether (2-ME) and validation of a physiologically based pharmacokinetic model for the pregnant rat and human
M L Gargas, T R Tyler, L M Sweeney, et al.
Toxicology and Applied Pharmacology
|
May 18, 2000
A toxicokinetic study of inhaled ethylene glycol ethyl ether acetate and validation of a physiologically based pharmacokinetic model for rat and human
M L Gargas, T R Tyler, L M Sweeney, et al.
Toxicology and Applied Pharmacology
|
September 15, 1990
Estimating the risk of liver cancer associated with human exposures to chloroform using physiologically based pharmacokinetic modeling
R H Reitz, A L Mendrala, R A Corley, et al.
Toxicology and Applied Pharmacology
|
May 1, 1990
Development of a physiologically based pharmacokinetic model for chloroform
R A Corley, A L Mendrala, F A Smith, et al.
Inhalation Toxicology
|
June 13, 2009
Magnetic resonance imaging and computational fluid dynamics (CFD) simulations of rabbit nasal airflows for the development of hybrid CFD/PBPK models
R A Corley, K R Minard, S Kabilan, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 62) with videos related to
Sort By:
Page
of 7
Toxicology and Applied Pharmacology
|
May 18, 2000
A physiological toxicokinetic model for exogenous and endogenous ethylene and ethylene oxide in rat, mouse, and human: formation of 2-hydroxyethyl adducts with hemoglobin and DNA
G A Csanády, B Denk, C Pütz, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis
|
February 1, 1993
Modeling receptor-mediated processes with dioxin: implications for pharmacokinetics and risk assessment
M E Andersen, J J Mills, M L Gargas, et al.
Regulatory Toxicology and Pharmacology : RTP
|
August 16, 2005
Cancer dose--response assessment for acrylonitrile based upon rodent brain tumor incidence: use of epidemiologic, mechanistic, and pharmacokinetic support for nonlinearity
C R Kirman, M L Gargas, G M Marsh, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis
|
November 26, 2004
Addressing nonlinearity in the exposure-response relationship for a genotoxic carcinogen: cancer potency estimates for ethylene oxide
C R Kirman, L M Sweeney, M J Teta, et al.
Toxicology and Applied Pharmacology
|
March 15, 1991
Physiologically based pharmacokinetic modeling with dichloromethane, its metabolite, carbon monoxide, and blood carboxyhemoglobin in rats and humans
M E Andersen, H J Clewell, M L Gargas, et al.
Toxicology and Applied Pharmacology
|
May 18, 2000
A toxicokinetic study of inhaled ethylene glycol monomethyl ether (2-ME) and validation of a physiologically based pharmacokinetic model for the pregnant rat and human
M L Gargas, T R Tyler, L M Sweeney, et al.
Toxicology and Applied Pharmacology
|
May 18, 2000
A toxicokinetic study of inhaled ethylene glycol ethyl ether acetate and validation of a physiologically based pharmacokinetic model for rat and human
M L Gargas, T R Tyler, L M Sweeney, et al.
Toxicology and Applied Pharmacology
|
September 15, 1990
Estimating the risk of liver cancer associated with human exposures to chloroform using physiologically based pharmacokinetic modeling
R H Reitz, A L Mendrala, R A Corley, et al.
Toxicology and Applied Pharmacology
|
May 1, 1990
Development of a physiologically based pharmacokinetic model for chloroform
R A Corley, A L Mendrala, F A Smith, et al.
Inhalation Toxicology
|
June 13, 2009
Magnetic resonance imaging and computational fluid dynamics (CFD) simulations of rabbit nasal airflows for the development of hybrid CFD/PBPK models
R A Corley, K R Minard, S Kabilan, et al.
Page
of 7